Clinical Trial Update: rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT) [Phase 3]

View source ↗

Summary

A Phase 3 study comparing rATG alone versus rATG with IVIG for induction immunosuppression in HLA-incompatible kidney transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• IVIG (intravenous immunoglobulin)
• rATG (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Institute for Clinical and Experimental Medicine | Conditions: Kidney Transplantation | Phase 3 | Status: COMPLETED